(firstQuint)Dacarbazine and Carmustine in Metastatic Melanoma.

 In this phase II trial, patients with stage IV melanoma will be treated with dacarbazine and carmustine commonly used in this cancer, but given using a schedule that might theoretically improve on this combination.

 Patients on this study will be assessed in terms of toxicity, response rate, median duration of response, median time to disease progression, and median survival.

.

 Dacarbazine and Carmustine in Metastatic Melanoma@highlight

The purpose of this study is to determine whether dacarbazine and carmustine at the doses and schedule used in this study will help to increase tumor shrinkage.

